Backed by our rich industrial experience in this domain we are devotedly engaged in offering Levosalbutamol 1.25 mg and Ipratropium Bromide 500 mcg Inhalation Solution. The offered solution is formulated in compliance with medical standards. Our offered solution is used in the treatment of chronic obstructive pulmonary disease. Our offered Levosalbutamol 1.25 mg and Ipratropium Bromide 500 mcg Inhalation Solution is made available in a gradation of packaging options, in order to facilitate safer deliveries.